EGFR and non-small cell lung carcinoma: Because of the low incidence of the ex20 ins/dup in NSCLC, there have been a limited number of comprehensive studies published, and about half of the existing studies were performed in the Asian population with a focus on EGFR ex20 ins/dup only.